$DORM
Dorman Products, Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021037979 Filed on July 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $310.6M $233.2M $257.7M
YoY Change 33.22% -8.26% 5.72%
Cost Of Revenue $200.5M $154.0M $172.9M
YoY Change 30.2% -7.8% 10.62%
Gross Profit $110.1M $79.10M $84.80M
YoY Change 39.22% -9.23% -3.09%
Gross Profit Margin 35.45% 33.92% 32.9%
Selling, General & Admin $69.52M $61.50M $59.70M
YoY Change 13.04% 2.84% 3.38%
% of Gross Profit 63.13% 77.75% 70.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.550M $7.500M $7.500M
YoY Change 27.33% 10.29% 2.74%
% of Gross Profit 8.67% 9.48% 8.84%
Operating Expenses $69.52M $61.60M $59.80M
YoY Change 12.85% 2.67% 3.55%
Operating Profit $40.61M $17.50M $25.06M
YoY Change 132.05% -35.72% -15.74%
Interest Expense $63.00K
YoY Change
% of Operating Profit 0.16%
Other Income/Expense, Net $153.0K -$300.0K $2.631M
YoY Change -151.0% 8972.41%
Pretax Income $40.70M $17.30M $27.69M
YoY Change 135.25% -36.63% -6.98%
Income Tax $9.080M $3.400M $4.918M
% Of Pretax Income 22.31% 19.65% 17.76%
Net Earnings $31.62M $13.89M $22.78M
YoY Change 127.71% -35.42% -2.7%
Net Earnings / Revenue 10.18% 5.95% 8.84%
Basic Earnings Per Share $0.99 $0.43 $0.70
Diluted Earnings Per Share $0.99 $0.43 $0.70
COMMON SHARES
Basic Shares Outstanding 31.94M 32.27M 32.35M
Diluted Shares Outstanding 32.09M 32.34M 32.43M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $155.5M $359.6M $161.8M
YoY Change -56.75% 836.46% 296.57%
Cash & Equivalents $155.5M $359.6M $161.8M
Short-Term Investments
Other Short-Term Assets $16.07M $10.40M $10.80M
YoY Change 54.51% -40.57% 45.95%
Inventory $356.8M $274.8M $258.4M
Prepaid Expenses
Receivables $446.2M $241.9M $423.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $974.6M $886.7M $854.3M
YoY Change 9.91% 22.42% 34.62%
LONG-TERM ASSETS
Property, Plant & Equipment $126.5M $131.9M $99.08M
YoY Change -4.13% 28.93% -2.28%
Goodwill $91.16M $91.28M
YoY Change 25.56% 25.72%
Intangibles $27.75M
YoY Change 12.51%
Long-Term Investments
YoY Change
Other Assets $53.82M $43.00M $44.30M
YoY Change 25.15% -17.03% -16.72%
Total Long-Term Assets $294.9M $292.9M $298.5M
YoY Change 0.67% 0.33% 1.92%
TOTAL ASSETS
Total Short-Term Assets $974.6M $886.7M $854.3M
Total Long-Term Assets $294.9M $292.9M $298.5M
Total Assets $1.269B $1.180B $1.153B
YoY Change 7.62% 16.07% 24.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $126.5M $83.80M $73.28M
YoY Change 50.91% -18.09% -25.44%
Accrued Expenses $206.1M $142.9M $142.3M
YoY Change 44.2% 813.98% 384.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $99.00M $99.00M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $332.5M $325.6M $314.5M
YoY Change 2.13% 51.81% 134.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.41M $43.20M $13.30M
YoY Change -6.45% 208.24% -6.42%
Total Long-Term Liabilities $40.41M $43.20M $13.30M
YoY Change -6.45% 208.24% -6.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $332.5M $325.6M $314.5M
Total Long-Term Liabilities $40.41M $43.20M $13.30M
Total Liabilities $376.5M $372.5M $327.8M
YoY Change 1.07% 63.02% 121.32%
SHAREHOLDERS EQUITY
Retained Earnings $737.6M
YoY Change 6.67%
Common Stock $53.78M
YoY Change 7.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $893.0M $807.1M $791.4M
YoY Change
Total Liabilities & Shareholders Equity $1.269B $1.180B $1.153B
YoY Change 7.62% 16.07% 24.29%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $31.62M $13.89M $22.78M
YoY Change 127.71% -35.42% -2.7%
Depreciation, Depletion And Amortization $9.550M $7.500M $7.500M
YoY Change 27.33% 10.29% 2.74%
Cash From Operating Activities $18.09M $200.8M $18.59M
YoY Change -90.99% 899.0% 13.14%
INVESTING ACTIVITIES
Capital Expenditures -$3.953M -$3.600M $3.505M
YoY Change 9.81% -57.65% -60.34%
Acquisitions $14.46M
YoY Change
Other Investing Activities $200.0K -$14.50M
YoY Change
Cash From Investing Activities -$3.953M -$3.500M -$17.97M
YoY Change 12.94% -58.82% 103.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -25.17M 500.0K 92.80M
YoY Change -5134.2% -103.6% -1004.77%
NET CHANGE
Cash From Operating Activities 18.09M 200.8M 18.59M
Cash From Investing Activities -3.953M -3.500M -17.97M
Cash From Financing Activities -25.17M 500.0K 92.80M
Net Change In Cash -11.04M 197.8M 93.43M
YoY Change -105.58% -8700.0% -3606.94%
FREE CASH FLOW
Cash From Operating Activities $18.09M $200.8M $18.59M
Capital Expenditures -$3.953M -$3.600M $3.505M
Free Cash Flow $22.04M $204.4M $15.09M
YoY Change -89.22% 614.69% 98.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10886000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9194000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32168740
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2493000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
807132000
dorm Stock Issued During Period Value Restricted Stock Award Cancelled Net Of Issuances
StockIssuedDuringPeriodValueRestrictedStockAwardCancelledNetOfIssuances
-505000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
853559000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
736000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-462000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
31618000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
892985000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
791375000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
13885000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4491000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
31249000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2493000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1393000
us-gaap Net Income Loss
NetIncomeLoss
64348000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
892985000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
773584000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32168740
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
883811000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
420000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2380000
CY2021Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
27275000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1504000
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
86000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
506000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-52000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
359558000
us-gaap Interest Paid Net
InterestPaidNet
433000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
736000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
120000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
5865000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
93255000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
291205000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1750000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
433700000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
496400000
dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
CY2021Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
163429000
CY2020Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
136726000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
188250000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
157484000
CY2021Q2 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
5080000
CY2020Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
4509000
CY2021Q2 us-gaap Inventory Net
InventoryNet
356759000
CY2020Q4 us-gaap Inventory Net
InventoryNet
298719000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
10400000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8000000.0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2400000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2400000
us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
16000000.0
dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
310635000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233182000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
598647000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
490912000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
310635000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233182000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
598647000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
490912000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
217735
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
72.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
52001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
111.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
33676
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
66.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
42227
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
74.56
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
193833
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
83.95
CY2021Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
CY2020Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
600000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
500000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
250779
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
57056
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
101.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5540
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
81.71
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37534
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
65.48
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
264761
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
77.38
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6101198000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94722
CY2021Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
73.70
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2506557000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
123000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
107000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
31618000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
13885000
us-gaap Net Income Loss
NetIncomeLoss
64348000
us-gaap Net Income Loss
NetIncomeLoss
36660000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31942000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32269000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31995000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32312000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
147000
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
69000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
141000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
76000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32089000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32338000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32136000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32388000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.01
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1200000
CY2020 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1800000
dorm Lease Effective Date
LeaseEffectiveDate
2018-01-01

Files In Submission

Name View Source Status
0001564590-21-037979-index-headers.html Edgar Link pending
0001564590-21-037979-index.html Edgar Link pending
0001564590-21-037979.txt Edgar Link pending
0001564590-21-037979-xbrl.zip Edgar Link pending
dorm-10q_20210626.htm Edgar Link pending
dorm-10q_20210626_htm.xml Edgar Link completed
dorm-20210626.xsd Edgar Link pending
dorm-20210626_cal.xml Edgar Link unprocessable
dorm-20210626_def.xml Edgar Link unprocessable
dorm-20210626_lab.xml Edgar Link unprocessable
dorm-20210626_pre.xml Edgar Link unprocessable
dorm-ex311_6.htm Edgar Link pending
dorm-ex312_7.htm Edgar Link pending
dorm-ex32_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gzb1qbqow2hn000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending